Renaissance Technologies’s Seres Therapeutics MCRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-40,850
Closed -$1.14M 3925
2023
Q4
$1.14M Buy
+40,850
New +$1.14M ﹤0.01% 2318
2023
Q2
Sell
-19,910
Closed -$2.26M 4127
2023
Q1
$2.26M Sell
19,910
-7,665
-28% -$869K ﹤0.01% 1954
2022
Q4
$3.09M Buy
27,575
+630
+2% +$70.6K ﹤0.01% 1802
2022
Q3
$3.46M Sell
26,945
-16,875
-39% -$2.17M ﹤0.01% 1667
2022
Q2
$3.01M Buy
43,820
+19,850
+83% +$1.36M ﹤0.01% 1907
2022
Q1
$3.41M Sell
23,970
-13,355
-36% -$1.9M ﹤0.01% 1840
2021
Q4
$6.22M Buy
+37,325
New +$6.22M 0.01% 1381
2021
Q2
Sell
-6,460
Closed -$2.66M 3660
2021
Q1
$2.66M Buy
6,460
+1,410
+28% +$581K ﹤0.01% 2033
2020
Q4
$2.48M Sell
5,050
-13,790
-73% -$6.76M ﹤0.01% 1989
2020
Q3
$10.7M Sell
18,840
-50,825
-73% -$28.8M 0.01% 1082
2020
Q2
$6.63M Buy
69,665
+15,825
+29% +$1.51M 0.01% 1467
2020
Q1
$3.84M Sell
53,840
-1,930
-3% -$138K ﹤0.01% 1712
2019
Q4
$3.85M Buy
55,770
+1,810
+3% +$125K ﹤0.01% 2009
2019
Q3
$4.33M Buy
53,960
+1,790
+3% +$144K ﹤0.01% 1875
2019
Q2
$3.36M Buy
52,170
+7,060
+16% +$455K ﹤0.01% 2054
2019
Q1
$6.2M Buy
45,110
+4,865
+12% +$668K 0.01% 1672
2018
Q4
$3.64M Buy
40,245
+2,415
+6% +$218K ﹤0.01% 1923
2018
Q3
$5.74M Buy
37,830
+1,235
+3% +$187K 0.01% 1710
2018
Q2
$6.29M Sell
36,595
-7,295
-17% -$1.25M 0.01% 1629
2018
Q1
$6.44M Sell
43,890
-1,670
-4% -$245K 0.01% 1655
2017
Q4
$9.24M Buy
45,560
+14,915
+49% +$3.02M 0.01% 1438
2017
Q3
$9.83M Buy
30,645
+7,630
+33% +$2.45M 0.01% 1337
2017
Q2
$5.2M Buy
23,015
+5,475
+31% +$1.24M 0.01% 1686
2017
Q1
$3.95M Sell
17,540
-2,475
-12% -$558K 0.01% 1832
2016
Q4
$3.96M Buy
20,015
+5,190
+35% +$1.03M 0.01% 1821
2016
Q3
$3.64M Buy
+14,825
New +$3.64M 0.01% 1810
2015
Q4
Sell
-545
Closed -$323K 3364
2015
Q3
$323K Buy
+545
New +$323K ﹤0.01% 2745